DIFFERENTIATED APPROACH TO THE TREATMENT OF CHRONIC GASTRITIS, TAKING INTO ACCOUNT GENETIC MARKERS

Authors

  • Gulrukh Saidovna Ochilova Department of Pharmacology and Clinical Pharmacology Bukhara State Medical Institute, Uzbekistan

Keywords:

genotyping, cytochrome P450, gene polymorphism, MDR-1 gene, chronic gastritis, personification of pharmacotherapy

Abstract

Genotyping of patients to improve pharmacotherapy with chronic gastritis by the MDR1 gene, which provides the pharmacokinetics of drugs used for pharmacotherapy, contributed to improving the effectiveness, safety and personalization of pharmacotherapy, which serves to improve the quality of life of patients.

Downloads

Published

2022-07-18

How to Cite

Ochilova, G. S. . (2022). DIFFERENTIATED APPROACH TO THE TREATMENT OF CHRONIC GASTRITIS, TAKING INTO ACCOUNT GENETIC MARKERS. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 2(7), 45–50. Retrieved from https://inovatus.es/index.php/ejmmp/article/view/1093

Issue

Vol. 2 No. 7 (2022): EJMMP

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.